GSA CAPITAL PARTNERS LLP PLRX PLIANT THERAPEUTICS INC

Ownership history in GSA CAPITAL PARTNERS LLP  ·  13 quarters on record

AI Ownership Summary

GSA CAPITAL PARTNERS LLP reported PLIANT THERAPEUTICS INC (PLRX) in 13 quarterly 13F filings from 2025 Q1 through 2026 Q1. Peak portfolio weight reached 0.07% in 2025 Q4. The latest visible filing shows PLRX at 0.03% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this PLRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was GSA CAPITAL PARTNERS LLP's position in PLIANT THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

PLRX was reported at 0.03% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.07% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How GSA CAPITAL PARTNERS LLP held PLRX — position size vs. price
% of Fund (quarterly)    PLRX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 402,092 -221,606 -35.5% 0.03% $507 2026-05-08 $1.22
2025 Q4 ADDED 623,698 +462,814 +287.7% 0.07% $761K 2026-02-06 $1.14
2025 Q3 ADDED 160,884 +146,742 +1037.6% 0.02% $238K 2025-11-07 $1.60
2025 Q2 REDUCED 59.2% +28.4% 14,142 -20,530 -59.2% 0.00% $16K 2025-07-22 $1.57
2025 Q1 REDUCED 23.9% -14.1% 34,672 -10,915 -23.9% 0.00% $47K 2025-05-08 $1.46
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About GSA CAPITAL PARTNERS LLP and PLRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has GSA CAPITAL PARTNERS LLP reported owning PLRX?

GSA CAPITAL PARTNERS LLP reported PLRX across 5 quarterly 13F filings, from 2025 Q1 through 2026 Q1.

What was the largest reported PLRX position in GSA CAPITAL PARTNERS LLP's portfolio?

The largest reported portfolio weight for PLRX was 0.07% in 2025 Q4.

What is the latest reported PLRX position on this page?

The most recent filing on this page is 2026 Q1, when GSA CAPITAL PARTNERS LLP reported 402,092 shares, equal to 0.03% of portfolio, with an estimated market value of $507.

What does the chart on this PLRX ownership page compare?

The chart compares GSA CAPITAL PARTNERS LLP's quarterly PLRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did GSA CAPITAL PARTNERS LLP time their PLRX position?

Based on 13F filing dates vs. subsequent PLRX price moves, GSA CAPITAL PARTNERS LLP correctly timed 4 out of 12 reported position changes (33%).

← Back to GSA CAPITAL PARTNERS LLP Holdings